Bellicum Pharmaceuticals (BLCM)

Bellicum Pharmaceuticals (BLCM) Financial Statements


Bellicum Pharmaceuticals Financial Overview

Bellicum Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.494; its P/E ratio is -0.59; Bellicum Pharmaceuticals is scheduled to report earnings on May 11, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 1.00M$ 0.00$ 0.00$ 500.00K$ 5.00M
Gross Profit-----
EBIT$ -7.21M$ -4.00M$ -7.56M$ 2.53M$ 1.23M
EBITDA$ -7.21M$ -4.00M$ -7.56M$ 2.55M$ 1.25M
Net Income Common Stockholders$ -7.21M$ -4.00M$ -7.56M$ 2.53M$ 764.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 28.76M$ 33.17M$ 39.77M$ 46.16M$ 19.27M
Total Assets$ 31.28M$ 36.60M$ 43.43M$ 49.14M$ 22.37M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -28.76M$ -33.17M$ -39.77M$ -46.16M$ -19.27M
Total Liabilities$ 23.78M$ 22.57M$ 26.00M$ 24.75M$ 34.54M
Stockholders Equity$ 7.50M$ 14.04M$ 17.43M$ 24.39M$ -12.16M
Cash Flow-
Free Cash Flow$ -5.91M$ -6.60M$ -6.38M$ -6.03M$ -1.00M
Operating Cash Flow$ -5.91M$ -6.59M$ -6.38M$ -6.03M$ -996.00K
Investing Cash Flow$ 0.00$ -7.00K$ -7.00K$ 0.00$ -7.00K
Financing Cash Flow$ 0.00$ 0.00$ 0.00$ 32.91M$ 0.00
Currency in USD

Bellicum Pharmaceuticals Earnings and Revenue History

Bellicum Pharmaceuticals Debt to Assets

Bellicum Pharmaceuticals Cash Flow

Bellicum Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis